Similar articles

• Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.

  Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C, et al. Sarode R, et al. Bone Marrow Transplant. 1995 Aug;16(2):271-5. Bone Marrow Transplant. 1995. PMID: 7581147
• Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).

  Kakishita E. Kakishita E. Int J Hematol. 2000 Jun;71(4):320-7. Int J Hematol. 2000. PMID: 10905050 Review.
• Thrombotic microangiopathies in bone marrow and organ transplant patients.

  McLeod BC. McLeod BC. J Clin Apher. 2002;17(3):118-23. doi: 10.1002/jca.10030. J Clin Apher. 2002. PMID: 12378546 Review. No abstract available.
• Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation.

  Kolker O, Sviri S, Linton DM, Or R, Nagler A, Shapira MY. Kolker O, et al. Acta Haematol. 2001;105(3):156-8. doi: 10.1159/000046558. Acta Haematol. 2001. PMID: 11463989
• Plasma exchange as successful treatment of thrombotic thrombocytopenic purpura post autologous bone marrow transplant in a child.

  Plews DE, Turner ML, Wallace WH. Plews DE, et al. Bone Marrow Transplant. 2000 Mar;25(6):679-80. doi: 10.1038/sj.bmt.1702208. Bone Marrow Transplant. 2000. PMID: 10734305